缅北禁地

With the right policy support, pharmaceutical industry in Nepal could be instrumental in meeting the country’s ‘access to medicine’-related targets while developing domestic manufacturing base. The impending graduation from the least-developed country status may cause Nepal to lose flexibilities accorded to LDCs in terms of meeting intellectual property rights under different multilateral legal frameworks that govern the global IPR regime.